Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,000
Closed -$206K 151
2025
Q2
$206K Hold
5,000
﹤0.01% 120
2025
Q1
$209K Hold
5,000
﹤0.01% 119
2024
Q4
$293K Sell
5,000
-27,000
-84% -$1.6M ﹤0.01% 116
2024
Q3
$2.21M Buy
+32,000
New +$2.07M 0.01% 103
2024
Q2
Sell
-83,100
Closed -$7.81M 173
2024
Q1
$7.81M Buy
83,100
+80,100
+2,670% +$6.44M 0.03% 96
2023
Q4
$220K Buy
+3,000
New +$192K ﹤0.01% 124
2023
Q3
Sell
-150,476
Closed -$11.1M 169
2023
Q2
$11.1M Sell
150,476
-344,000
-70% -$26.2M 0.06% 89
2023
Q1
$39M Sell
494,476
-364,824
-42% -$26.3M 0.21% 66
2022
Q4
$58.7M Sell
859,300
-84,500
-9% -$5.37M 0.35% 61
2022
Q3
$50.1M Sell
943,800
-463,000
-33% -$27.7M 0.28% 70
2022
Q2
$88.3M Buy
1,406,800
+345,000
+32% +$21.2M 0.48% 57
2022
Q1
$68.3M Buy
1,061,800
+316,534
+42% +$21.6M 0.33% 63
2021
Q4
$62.5M Buy
+745,266
New +$59.7M 0.31% 59

Other funds holding BRKR

Thomas Steyer's BRKR Position: Q3 2025 in Review

Thomas Steyer sold out of Bruker (BRKR) in Q3 2025, closing a stake of 5,000 shares — an estimated $206K sold.

Thomas Steyer first reported a position in BRKR in Q4 2021 and held it in 13 quarters. The position peaked at $88.3M in Q2 2022. 339 funds tracked by Wall St. Rank hold BRKR as of Q3 2025.

  • Thomas Steyer reported no remaining Bruker position as of Q3 2025 after selling out during the quarter.
  • Thomas Steyer sold 5,000 Bruker shares in Q3 2025, an estimated $206K.
  • Thomas Steyer first reported a position in Bruker in Q4 2021 and held it in 13 quarters.
  • Thomas Steyer's Bruker position peaked at $88.3M in Q2 2022.
  • 339 funds tracked by Wall St. Rank held Bruker as of Q3 2025.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.